BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28017807)

  • 1. Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study.
    Woo Y; Goldner B; Ituarte P; Lee B; Melstrom L; Son T; Noh SH; Fong Y; Hyung WJ
    J Am Coll Surg; 2017 Apr; 224(4):546-555. PubMed ID: 28017807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Analysis with Extended Lymphadenectomy for Gastric Cancer: Removing Stage Migration from the Equation.
    Vuong B; Graff-Baker AN; Dehal A; Stern S; Fujita M; Goldfarb M; Bilchik AJ
    Am Surg; 2017 Oct; 83(10):1074-1079. PubMed ID: 29391098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative.
    Gholami S; Janson L; Worhunsky DJ; Tran TB; Squires MH; Jin LX; Spolverato G; Votanopoulos KI; Schmidt C; Weber SM; Bloomston M; Cho CS; Levine EA; Fields RC; Pawlik TM; Maithel SK; Efron B; Norton JA; Poultsides GA
    J Am Coll Surg; 2015 Aug; 221(2):291-9. PubMed ID: 26206635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.
    Smith DD; Schwarz RR; Schwarz RE
    J Clin Oncol; 2005 Oct; 23(28):7114-24. PubMed ID: 16192595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
    Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
    Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it necessary to dissect the posterior lymph nodes along the splenic vessels during total gastrectomy with D2 lymphadenectomy for advanced gastric cancer?
    Lin JX; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M
    Eur J Surg Oncol; 2017 Dec; 43(12):2357-2365. PubMed ID: 29032923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.
    Chen JH; Cai SR; Zhai ET; Chen SL; Wu KM; Song W; He YL
    Int J Clin Exp Pathol; 2015; 8(11):14365-73. PubMed ID: 26823752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefit of "D2-plus" gastrectomy in gastric cancer patients with duodenal invasion.
    Kumagai K; Sano T; Hiki N; Nunobe S; Tsujiura M; Ida S; Ohashi M; Yamaguchi T
    Gastric Cancer; 2018 Mar; 21(2):296-302. PubMed ID: 28584890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of lymph nodes count on survival of patients with node-negative gastric cancer.
    Zheng WF; Ji TT; Lin Y; Li RZ
    Oncotarget; 2016 Jul; 7(28):43680-43688. PubMed ID: 27270656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of a new staging system based on the retrieved number and metastatic rate of LNs in gastric cancer with ≤15 retrieved LNs.
    Tu RH; Lin JX; Wang W; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Zhou ZW; Zheng CH; Huang CM
    Eur J Surg Oncol; 2020 Dec; 46(12):2221-2228. PubMed ID: 32859432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit.
    Liu YY; Fang WL; Wang F; Hsu JT; Tsai CY; Liu KH; Yeh CN; Chen TC; Wu RC; Chiu CT; Yeh TS
    Oncologist; 2017 Jan; 22(1):97-106. PubMed ID: 27789777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
    Volpe CM; Driscoll DL; Douglass HO
    Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of spleen-preserving lymphadenectomy in total gastrectomy for gastric and esophagogastric junctional adenocarcinomas: A long-term retrospective propensity score match study from a high-volume institution in China.
    Liu K; Chen XZ; Zhang YC; Zhang WH; Chen XL; Sun LF; Yang K; Zhang B; Zhou ZG; Hu JK
    Surgery; 2021 Feb; 169(2):426-435. PubMed ID: 32950240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy.
    He H; Shen Z; Wang X; Qin J; Sun Y; Qin X
    Jpn J Clin Oncol; 2016 Jan; 46(1):63-70. PubMed ID: 26497044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.
    Schwarz RE; Smith DD
    Ann Surg Oncol; 2007 Feb; 14(2):317-28. PubMed ID: 17094022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
    Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
    J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
    Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
    Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do preoperative enlarged lymph nodes affect the oncologic outcome of laparoscopic radical gastrectomy for gastric cancer?
    Chen QY; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH
    Oncotarget; 2017 Jan; 8(5):8825-8834. PubMed ID: 27732971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.